Loading asset research
Caribou Biosciences Inc. Common Stock
CRBUNasdaq · USD · StocksQuote as of · Exchange session not verified$1.28
-6.57%
Today
CRBU
Loading 1D prices…
Market cap
$136.2M
Volume
2.4M
52w high
$3.5452w low
$1.26Company profile
Caribou Biosciences Inc. Common Stock
Caribou Biosciences, Inc. operates as a clinical-stage clustered regularly interspaced short palindromic repeats (CRISPR) genome-editing biopharmaceutical company. It offers a genome-editing platform based on novel CRISPR hybrid RNA-DNA genome-editing technology that enables precise genome editing of allogeneic cell therapies. The company develops Vispacabtagene Regedleucel, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy that is in phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. Caribou Biosciences, Inc. was incorporated in 2011 and is headquartered in Berkeley, California.
Sector
Health Care
Industry
Biological Products, (No Diagnostic Substances)
Exchange
Nasdaq
Display currency
USD
Location
Berkeley, CA, United States
Employees
97
Fiscal year end
1231
CIK
1619856
Session & valuation
Open$1.38
Previous close$1.37
Day high$1.40
Day low$1.26
30-day avg. volume1.1M
Outstanding shares107.2M
Diluted EPS-$1.59
Latest annual period
P/E (trailing)-0.81
P/E (forward)-1.01
Price / book1.37
Beta2.28
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2836
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LENZLENZ Therapeutics Inc. Common Stock | $142M | $19.1M | -430.25% | -$2.85 | -4.13% | Buy |
| TNYATenaya Therapeutics Inc. Common Stock | $143.5M | $0.00 | — | -$0.59 | -1.29% | Buy |
| ENGNenGene Therapeutics Inc. Common Stock | $120.6M | $0.00 | — | -$1.34 | +1.98% | Hold |
| HUMAHumacyte Inc. Common Stock | $157.7M | $2M | -2003.59% | -$0.26 | +0.25% | Buy |
| OTLKOutlook Therapeutics Inc. Common Stock | $160.7M | $1.4M | -3383.75% | -$0.51 | -0.50% | Buy |